Sphera Funds Management Ltd. Annexon, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $935,000 - $1.87 Million	250,000 New	250,000 $962,000
Q1 2022 May 16, 2022	SELL	$2.73 - $11.94 $337,529 - $1.48 Million	-123,637 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$16.35 - $23.4 $403,534 - $577,535	-24,681 Reduced 16.64%	123,637 $2.3 Million
Q2 2021 Aug 17, 2021	BUY	$17.81 - $27.48 $2.64 Million - $4.08 Million	148,318 New	148,318 $3.34 Million

158

102M

3.61M

1.08M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $312M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.